These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1719565)

  • 1. Role of hepatocyte proliferation in alpha-hexachlorocyclohexane and phenobarbital tumor promotion in B6C3F1 mice.
    Siglin JC; Weghorst CM; Klaunig JE
    Prog Clin Biol Res; 1991; 369():407-16. PubMed ID: 1719565
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between species and tissue sensitivity to chemical carcinogenesis in rodents and the induction of DNA synthesis.
    Klaunig JE; Siglin JC; Schafer LD; Hartnett JA; Weghorst CM; Olson MJ; Hampton JA
    Prog Clin Biol Res; 1991; 369():185-94. PubMed ID: 1946517
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation.
    Jirtle RL; Meyer SA; Brockenbrough JS
    Prog Clin Biol Res; 1991; 369():209-16. PubMed ID: 1946518
    [No Abstract]   [Full Text] [Related]  

  • 4. Gender-dependent differences in hepatic tumor promotion in diethylnitrosamine initiated infant B6C3F1 mice by alpha-hexachlorocyclohexane.
    Siglin JC; Weghorst CM; Rodwell DE; Klaunig JE
    J Toxicol Environ Health; 1995 Feb; 44(2):235-45. PubMed ID: 7531777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine.
    Lee GH; Ooasa T; Osanai M
    Cancer Res; 1998 Apr; 58(8):1665-9. PubMed ID: 9563480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
    Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
    Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 mice.
    Bachman AN; Phillips JM; Goodman JI
    Toxicol Sci; 2006 Jun; 91(2):393-405. PubMed ID: 16537655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
    Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
    Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth kinetics of microscopic hepatocellular neoplasms in carcinogen-resistant and carcinogen-responsive strains of mice.
    Pugh TD; Goldfarb S
    Cancer Res; 1992 Jan; 52(2):280-4. PubMed ID: 1728402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dieldrin and phenobarbital on preneoplastic hepatic lesion growth in male F344 rat and B6C3F1 mouse.
    Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
    Prog Clin Biol Res; 1995; 391():409-23. PubMed ID: 8532733
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversibility of promoter induced hepatic focal lesion growth in mice.
    Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
    Carcinogenesis; 1996 Jul; 17(7):1403-9. PubMed ID: 8706241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain differences in hepatic tumor promotion by phenobarbital in diethylnitrosamine- and dimethylnitrosamine-initiated infant male mice.
    Weghorst CM; Pereira MA; Klaunig JE
    Carcinogenesis; 1989 Aug; 10(8):1409-12. PubMed ID: 2752514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of apoptosis for mouse liver growth regulation and tumor promotion: comparative analysis of mice with high (C3H/He) and low (C57Bl/6J) cancer susceptibility.
    Bursch W; Grasl-Kraupp B; Wastl U; Hufnagl K; Chabicovsky M; Taper H; Schulte-Hermann R
    Toxicol Lett; 2004 Apr; 149(1-3):25-35. PubMed ID: 15093245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of adaptation to phenobarbital may cause selective growth of foci of altered cells in rat liver.
    Schulte-Hermann R; Timmermann-Trosiener I; Schuppler J
    IARC Sci Publ; 1984; (56):67-75. PubMed ID: 6152623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison in C3H and C3B6F1 mice of the sensitivity to diethylnitrosamine-initiation and phenobarbital-promotion to the extent of cell proliferation.
    Pereira MA
    Carcinogenesis; 1993 Feb; 14(2):299-302. PubMed ID: 8382116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin.
    Schulte-Hermann R; Ohde G; Schuppler J; Timmermann-Trosiener I
    Cancer Res; 1981 Jun; 41(6):2556-62. PubMed ID: 6165465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of hepatocellular foci and adenomas by di(2-ethylhexyl) phthalate and phenobarbital in C3H/HeNCr mice following exposure to N-nitrosodiethylamine at 15 days of age.
    Weghorst CM; Devor DE; Henneman JR; Ward JM
    Exp Toxicol Pathol; 1994 Feb; 45(7):423-31. PubMed ID: 8167465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic rate of liver tumors induced by diethylnitrosamine in mice.
    Kyriazis AP; Koka M; Vesselinovitch SD
    Cancer Res; 1974 Nov; 34(11):2881-6. PubMed ID: 4424283
    [No Abstract]   [Full Text] [Related]  

  • 20. Early responses of the liver of B6C3F1 mice to the hepatocarcinogen oxazepam.
    Cunningham ML; Maronpot RR; Thompson M; Bucher JR
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):31-8. PubMed ID: 8291059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.